In this week’s DeviceTalks Weekly Podcast, senior executives from Avail Medsystems and AliveCor detail how their tools are helping medtechs remain in contact with both physicians and patients. In the keynote interview with Daniel Hawkins, CEO of Avail Medsystems, says the company’s Procedural Telemedicine system will allow medical device sales representatives to observe more procedures […]
BD
The top 5 MassDevice stories of the week — October 2, 2020
Major medtech companies are making tuck-in acquisitions and investments as they seek innovations to help them grow out of the COVID-19 pandemic and resulting recession. That was a major takeaway from our top stories on MassDevice over the past week. Want to hear more about the week’s top news? Executive editor Chris Newmarker and Tom […]
BD is paying $60M to settle Bard pelvic mesh suits with most U.S. states
Becton Dickinson (NYSE:BDX) will pay $60 million to 48 U.S. states to resolve allegations that its C.R. Bard business deceptively marketed transvaginal surgical mesh devices, state attorneys general in California and Washington announced today. Mesh products were meant to treat the weakening of the muscles and ligaments supporting a woman’s pelvic organs, but they instead sparked […]
The top 5 MassDevice stories of the week — August 14, 2020
COVID-19 continues to batter medical device companies — not to mention the world as a whole. But some of this week’s top five MassDevice stories demonstrate that medtech companies continue to innovate and ink business deals as they look toward a post-pandemic future. Want to hear more about the week’s top news? Executive editor Chris […]
Federal appeals court rejects preemption argument from BD’s Bard
The 9th U.S. Circuit Court of Appeals has handed down an important medical device preemption opinion as it affirmed a $3.6 million award against Becton Dickinson & Co. (NYSE:BDX) subsidiary C.R. Bard in a bellwether lawsuit case over inferior vena cava filters. Bard’s lawyers had argued that when FDA reclassified intravascular filters as Class II devices, the […]
The 18 most innovative medical devices of 2020
The Galien Foundation recently announced nominees for most innovative medical devices for its 14th Annual Prix Galien USA Awards. The foundation bestows the Prix Galien Award annually to examples of outstanding biomedical and technology products that are designed to improve the human condition. “As we celebrate 50 years of the Prix Galien process, we are honored […]
The top 5 medtech stories of the week — July 24, 2020
COVID-19 is surging back in the U.S., new jobless claims are up, but MassDevice’s most-read stories this week were mostly optimistic. That’s the takeaway from our inaugural MassDevice Top Five — a weekly recap of the most-read stories on MassDevice, the online business journal of the medical device industry. Want to hear more about the […]
Feds to buy hundreds of thousands of COVID-19 antigen tests from BD
The U.S. Departement of Health and Human Services is turning to the new COVID-19 antigen test from Becton Dickinson (NYSE:BDX) as it seeks to boost rapid point-of-care testing. HHS will buy 2,000 BD Veritor Plus systems and 750,000 SARS-CoV-2 antigen test kits for use in a broad, decentralized network, BD said today. The distribution of the […]
U.S. investing $42m to boost BD syringe and needle production
HHS’s Biomedical Advanced Research and Development Authority is helping BD expand operations and manufacturing capacity in Nebraska to boost syringe and needle supplies for an eventual COVID-19 vaccine. Becton Dickinson (NYSE:BDX) said today that the total project will cost $70 million, with BARDA providing $42 million. The company expects the new capacity to be online within […]
BD launches COVID-19 antigen test that can produce results in 15 minutes
Becton Dickinson (NYSE:BDX) announced today that it’s received an FDA emergency use authorization for its COVID-19 antigen test, which the company will start shipping this week. BD plans to ramp-up manufacturing capacity to 2 million tests per week by the end of September, with 10 million tests produced by the end of September. The tests run […]
Moody’s lowers its medical device industry earnings forecast
Medical device industry earnings will remain flat over the next 12 to 18 months as people hold off on medical procedures amid the COVID-19 pandemic and resulting recession, according to a new report from Moody’s. Moody’s had previously projected of 2–4% annual growth. “While underlying positive trends remain, including ongoing innovation and favorable longterm demographics, […]
